SEC Form D filing
Syncromune, Inc.
Biotech · Series D · Regulation D 506(b) · FL · Filed May 11, 2026
Offering amount
$144.8M
Exemption
Reg D 506(b)
Issuer state
FL
Filing date
May 11, 2026
Signature date
—
CIK
0001955312
Summary
Immunology/biotech company with $144M late-stage capital raise.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.